Listen to Dr. Keith Vossel's exclusive interview with KNX News Radio, aired on July 6, 2023, about the FDA’s full approval of the first-in-class Alzheimer’s drug, Lecanemab, for people with early stages of Alzheimer’s disease; studies showed it to slow progression in cognitive decline.
